Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit
25 sept. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen to Participate in the 75th Annual American Society for Surgery of the Hand Meeting
24 sept. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference
31 août 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. Reports Second Quarter 2020 Financial Results
05 août 2020 16h01 HE
|
Axogen, Inc.
ALACHUA, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
29 juil. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., July 29, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects
22 juil. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., July 22, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020
15 juil. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., July 15, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate
01 juil. 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced...
Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer
01 juin 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference
20 mai 2020 07h00 HE
|
Axogen, Inc.
ALACHUA, Fla., May 20, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...